Tag: Khiron Life Sciences
AusCann’s Chilean JV to kick off crop cultivation with Khiron Life Sciences
Australian medicinal cannabis company AusCann has announced that its 50:50 Chilean joint venture, DayaCann, will commence its first third party cannabis cultivation activity with Canadian...
Featured Article
From cost exposure to cost control: Using energy flexibility to protect margins
Electricity price volatility is reshaping the cost base of Australian manufacturing, challenging long-held assumptions that energy can be treated as a stable operational input.
